86 funding opportunities are listed in this category

Big Questions in Free Will Grants Program
John Templeton Foundation
All Regions
04/15/2010
$250,000

Big Questions in Free Will Grants Program

In January, 2010, with the support of a generous grant from the John Templeton Foundation, Florida State University launched a four-year project on free will — Big Questions in Free Will — directed by Alfred R. Mele, William H. and Lucyle T. Werkmeister Professor of Philosophy at Florida State University.

The primary purpose of the project is to improve our understanding of free will in three spheres: science (especially neuroscience and social psychology); philosophy; and theology.

Those interested in the BQFW project are encouraged to look also at the opportunity for grant funding currently available on the John Templeton Foundation website. The Foundation is offering funds for research on projects investigating (a) the evolution of free will or (b) factors that serve to enhance or diminish our abilities to exercise free will. Initial inquiries are due by April 15, 2010.

Budget range and term for individual projects: From $50,000 to $250,000 and for up to two years.

 

Academic, Neurobiologist, Neuroscientist, Psychologist
2010 Thomas E. Heftler Migraine Research Award
American Headache Society/Migraine Research Foundation
All Regions
03/25/2010
$10,000

2010 Thomas E. Heftler Migraine Research Award

The American Headache Society® (AHS) and the Migraine Research Foundation (MRF) announce the 2010 Thomas E. Heftler Migraine Research Award. The $10,000 award will recognize the most innovative research proposal in migraine by a neurology resident or headache medicine fellow in an accredited U.S. program. Both clinical and basic science proposals will be considered. Reviewers will look for innovation, impact, and importance to the field of migraine research.

The Migraine Research Foundation created and funded the award in memory of Mr. Heftler who was a founding member of the Board of Directors of the Migraine Research Foundation until his untimely death in June 2007. The Migraine Research Foundation is the only organization whose sole purpose is to raise funds for innovative scientific research to further the understanding of the causes and mechanisms of migraine, to develop improvements in treatment, and to find the cure.

The American Headache Society® is a professional organization comprised of physicians and other health care professionals dedicated to improving the care and lives of headache sufferers.

The criteria are: (1) the quality of the research proposal; (2) the potential for the research to contribute to the advancement of the field of headache medicine; and (3) the quality of the research environment. Awardees must submit a progress report after 6 months of work, an abstract to the 2012 AHS Annual Scientific Meeting to be reviewed for presentation, and a manuscript based on this work to the journal Headache. Headache has the first right of refusal for the manuscript.

To be considered for this award, the completed application form and all supporting documents must be received by the AHS Executive Offices no later than 5:00pm EST on March 25, 2010.

* Proposals due March 25, 2010
* Winner announced April 15, 2010
* Award research to commence July 1, 2010

Please contact the American Headache Society® if you have any questions.

American Headache Society®
19 Mantua Rd.
Mount Royal, NJ 08061
Phone: 856-423-0043
Fax: 856-423-0082
ahshq@talley.com

Junior Investigator, Junior Researcher, Junior Scientist, Neurochemist, Neurologist, Neuroscientist, New Investigator, New Researcher, Physician Researcher, Postdoctoral Fellow, Young Investigator, Young Scientist, Medical Resident
International Rett Syndrome Foundation HeART Award (Help Accelerate Rett Therapeutics)
International Rett Syndrome Foundation
All Regions
08/16/2010
$50,000
International Rett Syndrome Foundation HeART Award (Help Accelerate Rett Therapeutics)

Goal: To provide seed funding for early stage drug discovery and development efforts.

Funding: The program provides funding in amounts ranging from $25,000-$50,000 for one year with a high likelihood of follow-on funding for successful programs.

HeART Award Timeline

Cycle 1
LOIS due: March 26, 2010
Applications due: April 26, 2010

Cycle 2

LOIs due: August 16, 2010
Applications due: September 30, 2010

International Rett Syndrome Foundation
4600 Devitt Drive
Cincinnati OH 45246

Telephone: 1-800-818-7388
Fax: 1-513-874-2520
Neurologist, Neuroscientist, Pharmacologist, Physician Researcher
International Rett Syndrome Foundation HeART Award (Help Accelerate Rett Therapeutics)
International Rett Syndrome Foundation
All Regions
03/26/2010
$50,000

International Rett Syndrome Foundation HeART Award (Help Accelerate Rett Therapeutics)

Goal: To provide seed funding for early stage drug discovery and development efforts.

Funding: The program provides funding in amounts ranging from $25,000-$50,000 for one year with a high likelihood of follow-on funding for successful programs.

HeART Award Timeline

Cycle 1
LOIS due: March 26, 2010
Applications due: April 26, 2010

Cycle 2

LOIs due: August 16, 2010
Applications due: September 30, 2010

International Rett Syndrome Foundation
4600 Devitt Drive
Cincinnati OH 45246

Telephone: 1-800-818-7388
Fax: 1-513-874-2520

Neurologist, Neuroscientist, Pharmacologist, Physician Researcher
2010 Ivy Request for Proposals
Ben and Catherine Ivy Foundation
All Regions
03/22/2010
$150,000
2010 Ivy Request for Proposals

The Ben and Catherine Ivy Foundation is a non-profit organization that funds Patient-Focused Research on gliomas leading to the development of better diagnostics and treatment that offer long-term survival and a high quality of life for patients with brain tumors. Since our inception in 2007, the Foundation has funded $20.2M in glioma research.

Guided by its strategic plan and mission, the Ivy Foundation is interested in funding projects on the leading edge whose primary objective is to accomplish one or more of the following in a 12-month project period starting no later than July 2010:

Enhance the output of a clinical trial for adults with GBM by performing correlative studies which significantly increase understanding of the biologic impact of a candidate therapeutic and/or interpretation of clinical response data.
Identify or validate predictors of therapeutic responsiveness by GBM molecular subtype that could potentially lead to patient stratification for therapy selection.
Determine preliminary efficacy of novel candidate therapies or validate novel therapeutic targets in GBM models.

Research proposals MUST:

Focus on one or more of the three objectives outlined above, AND
Generate definitive results that are actionable, AND
Focus on adult GBM, AND
Clearly delineate relevance of GBM model to patient tumor biology (if employing GBM model).
Successful applications will LIKELY:

Involve conducting studies in patients or in patient-derived tissue specimens.
Be collaborative, multi-institutional and/or multi-disciplinary efforts.
Have clinical outcomes data available very early on in project period if study is related to a clinical trial.

Deadline for receipt of proposals: Monday, 03/22/2010 at 12 noon (Pacific Time).
Project period: 12 months.
Total funds to be distributed: up to $1M.
Total budget per project: up to $150,000 maximum.
Scientific review process: Two-step process comprised of an Intermediate Scientific Review followed by a Final Scientific Review.
Notification to all applicants of outcome of the Intermediate Scientific Review: May 2010.
Notification of outcome of the Final Scientific Review: June 2010.

Eligibility: Only early-career researchers who received their MD and/or PhD in the last 10 years (i.e., in 2000 or after) are eligible to apply as Principal Investigator (PI) or co-PI. (Postdoctoral fellows are eligible to apply). Both the PI and co-PI must meet the eligibility requirements for early career researcher. Applicants must be affiliated with a non-profit institution or for-profit organization in the US or abroad. Joint applications between academic institution(s) and for-profit entities are accepted. There is no limit on the number of applications per PI or per institution. PIs of projects currently receiving Ivy funding are not eligible to apply as PI or co-PI.
Project start date: July 2010.

If you have any questions about the RFP, please email the Ivy Foundation at info@ivyfoundation.org. The Foundation does not set up meetings or phone calls to discuss the specifics of any research project.

For more information about the Ben and Catherine Ivy Foundation, please contact us at:
505 Hamilton Avenue, Suite 300
Palo Alto, CA 94301
Tel. 650.324.3000
Email: info@ivyfoundation.org
Junior Faculty, Junior Investigator, Junior Researcher, Junior Scientist, Molecular Biologist , New Investigator, New Researcher, Oncologist, Physician Researcher, Postdoctoral Fellow, Young Investigator, Young Scientist
2010 Award for Research in Psychiatry Call for Submissions
American Psychiatric Association
All Regions
08/27/2010
$5,000

2010 Award for Research in Psychiatry Call for Submissions

The American Psychiatric Association takes pleasure in inviting submissions for the 2010 American Psychiatric Association Award for Research in Psychiatry. First awarded in 1949 as The Hofheimer Prize, this is the most significant award given for research by the American Psychiatric Association. It is given in recognition of a single distinguished contribution, a body of work, or a lifetime contribution that has had a major impact on the field and/or altered the practice of psychiatry. The Award is intended to cover the full spectrum of psychiatric research.

The Award consists of a $5,000 prize and an honorary plaque to be presented at APA's Annual Meeting in May. The Award also includes an honorary lecture by the awardee.

Candidates for the Award must be citizens of the United States or Canada and be nominated by a sponsor. Sponsors must be members of the American Psychiatric Association. Members of the Award Committee are excluded from submitting nominations.

The sponsor should submit a letter setting out in detail the justification for the nomination, summarizing the nominee's research accomplishments in a specific area, or the coherent theme of the research.

The nominee should submit:

A summary statement emphasizing the principle theme running through the work, its internal cohesiveness and consistency, and scientific implications
An up-to-date Curriculum Vitae, and
An up-to-date Bibliography. 

 Please note that it is no longer necessary for applicants to submit copies of relevant books and/or journal articles.

All entries should be submitted electronically to Harold Goldstein, Ph.D., APA Division of Research, email: goharold@psych.org

The Award is based on an annual competition and awardees are selected by APA's Committee on Research Awards, Stuart C. Yudofsy, M.D., Chair. Prior applicants who wish to reapply may do so by resubmitting in the next award cycle. For more information please contact Harold Goldstein, Ph.D., by email or by phone at (703) 907-8623.

Deadline for receipt of submissions is August 27, 2010

American Psychiatric Association
1000 Wilson Boulevard
Suite 1825
Arlington, VA 22209
Questions?
Contact APA Answer Center
Call Toll-Free: 1-888-35-PSYCH or 1-888-35-77924
From outside the U.S. and Canada call: 1-703-907-7300
Email: apa@psych.org

Distinguished Investigator, Distinguished Scholar, Distinguished Scientist, Physician Researcher, Psychiatrist , Senior Investigator, Senior Researcher
American Psychiatric Association and the American Association of Chairs of Departments of Psychiatry Research Mentorship Award: Call for Submissions
American Psychiatric Association/American Association of Chairs of Departments of Psychiatry
All Regions
08/27/2010
$1,500

American Psychiatric Association and the American Association of Chairs of Departments of Psychiatry Research Mentorship Award: Call for Submissions

On behalf of the American Psychiatric Association and the American Association of Chairs of Departments of Psychiatry, we are inviting submissions for the 2010 APA/AACDP Research Mentorship Award.

This award honors an academic psychiatrist who has in a significant traditional or innovative manner, fostered the pursuit of student research within his/her university department. The nominee’s contribution may be through direct mentorship of individual students, or by the promotion of novel research-oriented training activities within a department or residency program. The award consists of an inscribed plaque and a $1,500 honorarium, to be presented at the APA Annual Meeting.

Only one nomination from any department will be considered. Candidates for the award need not be limited to senior, well-established candidates; innovativeness and dedication will be honored any academic level. Nominees must be members of APA.

The award recipient will be selected by the APA Committee on Research Awards, Stuart C. Yudofsky, M.D., Chair.

The nomination package, which should be submitted electronically, should include:

A nomination letter describing the contribution(s) of the nominee to the department/residency program and/or to the people mentored.
A representative list of mentees or other beneficiaries of a specific research training program fostered by the nominee.
The nominee’s curriculum vitae.
The nomination package should be submitted to Harold Goldstein, Ph.D., APA Division of Research: email: goharold@psych.org telephone: (703) 907-8623

Please note the Submission Deadline of Friday, August 27, 2010.

American Psychiatric Association
1000 Wilson Boulevard
Suite 1825
Arlington, VA 22209

Questions?
Contact APA Answer Center
Call Toll-Free: 1-888-35-PSYCH or 1-888-35-77924
From outside the U.S. and Canada call: 1-703-907-7300
Email: apa@psych.org

Distinguished Investigator, Distinguished Scholar, Distinguished Scientist, Medical School Faculty, Mentor, Physician Researcher, Psychiatrist , Senior Investigator, Senior Researcher, Established Investigator, Junior Faculty, Educator
BD Biosciences Research Grant Program
BD Biosciences
All Regions
09/03/2010
$0

BD Biosciences Research Grant Program

Grant applications can be submitted by US scientists focused on stem cell research, multicolor flow cytometry, cell signaling, cancer research, immune function, infectious diseases, or neuroscience research.

The BD Biosciences Research Grant Program aims to reward and enable important research by providing vital funding for scientists pursuing innovative experiments to advance the scientific understanding of disease. Through its grant program, BD Biosciences works to support innovation in research and development, helping to define the next generation of scientific breakthroughs.

How to Apply
The application process is simple. Just write an abstract, complete the online application, review and accept the program terms and conditions, and submit.

Important Dates

Application start date: May 8, 2010
Application deadline: September 3, 2010
Winners to be announced December 11, 2010

Application Guidelines
We welcome your most innovative ideas and encourage you to submit abstracts within evolving research areas that include:

Stem cell research
Multicolor flow cytometry
Cell signaling
Cancer research
Immune function
Infectious diseases
Neuroscience research

Applications will be judged by a panel of distinguished scientists from academic and other research institutions. Awards will be based on the application's creativity, content, and innovation, including how you propose to use BD Biosciences reagents to further your research study's goals.

Before receiving awards, winners must sign a contract and other forms confirming eligibility and agreeing to abide by the rules of the grant.
BD
1 Becton Drive
Franklin Lakes, New Jersey
USA, 07417
201.847.6800

BD Biosciences
2350 Qume Drive
San Jose, California
USA, 95131
877.232.8995

Cell Biologist, Immunologist, Neuroscientist, Oncologist, Physician Researcher
Friedreich's Ataxia Research Alliance New Investigator Grants
Friedreich's Ataxia Research Alliance
All Regions
09/01/2010
$100,000

Friedreich's Ataxia Research Alliance New Investigator Grants

These grant awards are for young or new investigators who have demonstrated an interest in FA research and want to further that commitment. We believe in welcoming, mentoring and supporting new scientists in the FA research community so that they have the necessary experience and motivation to launch successful independent careers.

Guidelines for New Investigator Grants

New Investigator Grants are accepted twice a year March 1st and September 1st then awards are announced June 1st and December 1st.

The terms of the awards are July 1 – June 30 for awards submitted March 1st and January 1 – December 31 for awards submitted September 1st.

Grant proposals should not exceed 24 months in duration.

Grant awards are made in one year allocations. All subsequent payments are contingent upon receipt and satisfactory review of a progress report. FARA reserves the right terminate any grant award for inadequate progress, failure to submit reports, deviation in scope of the original research, and/or changes in funding priority.

All grants should be submitted using FARA’s Research Portfolio Management Program – www.curefa.org/rpmp

On the Main Grant Page of the application please indicate “NIA” in the RFP field.

A letter of support should be provided by the applicant’s supervisor/advisor.

A personal statement from the applicant should also be included that addresses the applicant’s current interests, career goals and interest in Friedreich’s ataxia research.

FARA only funds direct costs. No indirect costs will be awarded.

A detailed budget must be submitted with all proposals, including a justification to support reported expenses. Reasonable and customary salary support and benefits are acceptable for the applicant. The budget should not exceed $100,000.

Additional allowable expenses include: laboratory reagents and supplies, equipment, animal expenses, patient expenses directly related to study and not reimbursable by third party insurers, patient travel

Expenses not awarded: indirect costs/overhead, travel to meetings and conferences, membership to scientific societies

Individuals who receive this award cannot reapply through this same mechanism. This award is intended to help the scientist achieve additional sources of funding and independence.

If human subjects are used in the proposed study, the study must be approved by the Institutional Review Board (IRB). Full funding will not be provided until proof of IRB approval is demonstrated to FARA. Human subjects studied in the course of research conducted under a grant are under no circumstances a responsibility of FARA.

If animals are used in the proposed study, the study must be approved by the Institutional Animal Care and Use Committee (or equivalent) indicating that appropriate precautions have been taken to assure that proper treatment, care and humane conditions have been provided.

Friedreich's Ataxia Research Alliance
102 Pickering Way, Suite 200
Exton, PA 19341
USA

Phone: (484) 875-3015
Fax: (610) 363-1506
Email: info@cureFA.org
Website: www.cureFA.org

Junior Investigator, Junior Researcher, Junior Scientist, Neurologist, Neuroscientist, New Investigator, New Researcher, Physician Researcher, Young Investigator, Young Scientist
CUREPSP Society for Progressive Supranuclear Palsy Investigator-Initiated Research Projects
CUREPSP Society for Progressive Supranuclear Palsy
All Regions
04/01/2010
$75,000

CUREPSP Society for Progressive Supranuclear Palsy Investigator-Initiated Research Projects

Grant submission deadline is April 1, 2010

Two, CBD-related grants are available for up to $75,000 for a period of one to two years

VISION
Cure and prevent PSP and CBD

MISSION STATEMENT
Increase awareness of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD), fund research toward a cure and prevention, educate health professionals, and provide support, information and hope for persons and families with PSP and CBD.

The Society for Progressive Supranuclear Palsy (CurePSP) Research Program supports and promotes research that can advance the understanding and treatment of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD).

INVESTIGATOR-INITIATED RESEARCH
CurePSP promotes research that helps generate an integrated picture of PSP and CBD at the molecular, cellular, and clinical levels.

CurePSP is particularly interested in research that will help us:
1. Understand the role of the tau gene and other genes in PSP and CBD.
2. Understand the role of tau protein processing in PSP and CBD.
3. Understand cellular energy metabolism and oxidative stress perturbations in PSP and CBD.
4. Understand environmental factors that influence the development or course of PSP and CBD.
5. Understand the series of changes brain cells pass through in PSP and CBD as they progress
from healthy neurons to dysfunctional neurons.
6. Characterize the natural history of PSP and CBD in order to develop outcome measures for
clinical trials.
7. Develop animal models of PSP and CBD.
8. Develop tools and disease markers for early diagnosis of PSP and CBD and for assessment
of treatment.
9. Develop treatments that improve the symptoms of persons with PSP and CBD.
10. Develop interventions to arrest the progression of PSP and CBD and restore lost function.

CurePSP
Executive Plaza III
11350 McCormick Road, Suite 906
Hunt Valley, MD 21031

Phone: 800-457-4777
E-mail: info@curepsp.org
Website: www.curepsp.org

Neurologist, Neuroscientist, Physician Researcher, Scientist

23456789next